Profusa
PFSA | NASDAQ
$0.45
-$0.10 (-18.18%)
At close: Nov 12, 2026, 3:59 PM ET
$0.46
+$0.01 (+1.47%)
After-hours:
Nov 12, 2026, 7:52 PM ET
Profusa Company Profile
Company profile explainedCompany Profile
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Key Executives
| Name | Position |
|---|---|
| Jack E. Stover | Chief Executive Officer & Chairman |
| Fred S. Knechtel | Chief Financial Officer |
| Chung-Bin Hwang | President |
| David Icke | Head of Digital Health Business |
| Sean Givens | Head of Government Business |
| William McMillan | Co-founder, Chief Scientific Officer & Head of Research |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Profusa
| Country | United States |
| IPO Date | Jul 14, 2025 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Jack E. Stover |
Contact Details
626 Bancroft Way, Suite A Berkeley,
California 94710 United States
Stock Details
| Ticker Symbol | PFSA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001859807 |
| CUSIP Number | 74319X405 |
| ISIN Number | US74319X4051 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove PFSA